Charged Particles in Oncology
High-energy charged particles represent a cutting-edge technique in radiation oncology. Protons and carbon ions are used in several centers all over the world for the treatment of different solid tumors. Typical indications are ocular malignancies, tumors of the base of the skull, hepatocellular car...
Saved in:
Superior document: | Frontiers Research Topics |
---|---|
: | |
Year of Publication: | 2018 |
Language: | English |
Series: | Frontiers Research Topics
|
Physical Description: | 1 electronic resource (650 p.) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
993544277104498 |
---|---|
ctrlnum |
(CKB)4920000000094235 (oapen)https://directory.doabooks.org/handle/20.500.12854/43025 (EXLCZ)994920000000094235 |
collection |
bib_alma |
record_format |
marc |
spelling |
Marco Durante auth Charged Particles in Oncology Frontiers Media SA 2018 1 electronic resource (650 p.) text txt rdacontent computer c rdamedia online resource cr rdacarrier Frontiers Research Topics High-energy charged particles represent a cutting-edge technique in radiation oncology. Protons and carbon ions are used in several centers all over the world for the treatment of different solid tumors. Typical indications are ocular malignancies, tumors of the base of the skull, hepatocellular carcinomas and various sarcomas. The physical characteristics of the charged particles (Bragg peak) allow sparing of much more normal tissues than it is possible using conventional X-rays, and for this reason all pediatric tumors are considered eligible for protontherapy. Ions heavier than protons also display special radiobiological characteristics, which make them effective against radioresistant and hypoxic tumors. On the other hand, protons and ions with high charge (Z) and energy (HZE particles) represent a major risk for human space exploration. The main late effect of radiation exposure is cancer induction, and at the moment the dose limits for astronauts are based on cancer mortality risk. The Mars Science Laboratory (MSL) measured the dose on the route to Mars and on the planet’s surface, suggesting that a human exploration missions will exceed the radiation risk limits. Notwithstanding many studies on carcinogenesis induced by protons and heavy ions, the risk uncertainty remains very high. In this research topic we aim at gathering the experiences and opinions of scientists dealing with high-energy charged particles either for cancer treatment or for space radiation protection. Clinical results with protons and heavy ions, as well as research in medical physics and pre-clinical radiobiology are reported. In addition, ground-based and spaceflight studies on the effects of space radiation are included in this book. Particularly relevant for space studies are the clinical results on normal tissue complications and second cancers. The eBook nicely demonstrates that particle therapy in oncology and protection of astronauts from space radiation share many common topics, and can learn from each other. English carbon ions heavy ions Mars proton therapy radiotherapy particle radiobiology protons space radiation protection Charged particles space travel 2-88945-391-X Francis A. Cucinotta auth Jay S. Loeffler auth |
language |
English |
format |
eBook |
author |
Marco Durante |
spellingShingle |
Marco Durante Charged Particles in Oncology Frontiers Research Topics |
author_facet |
Marco Durante Francis A. Cucinotta Jay S. Loeffler |
author_variant |
m d md |
author2 |
Francis A. Cucinotta Jay S. Loeffler |
author2_variant |
f a c fac j s l jsl |
author_sort |
Marco Durante |
title |
Charged Particles in Oncology |
title_full |
Charged Particles in Oncology |
title_fullStr |
Charged Particles in Oncology |
title_full_unstemmed |
Charged Particles in Oncology |
title_auth |
Charged Particles in Oncology |
title_new |
Charged Particles in Oncology |
title_sort |
charged particles in oncology |
series |
Frontiers Research Topics |
series2 |
Frontiers Research Topics |
publisher |
Frontiers Media SA |
publishDate |
2018 |
physical |
1 electronic resource (650 p.) |
isbn |
2-88945-391-X |
illustrated |
Not Illustrated |
work_keys_str_mv |
AT marcodurante chargedparticlesinoncology AT francisacucinotta chargedparticlesinoncology AT jaysloeffler chargedparticlesinoncology |
status_str |
n |
ids_txt_mv |
(CKB)4920000000094235 (oapen)https://directory.doabooks.org/handle/20.500.12854/43025 (EXLCZ)994920000000094235 |
carrierType_str_mv |
cr |
hierarchy_parent_title |
Frontiers Research Topics |
is_hierarchy_title |
Charged Particles in Oncology |
container_title |
Frontiers Research Topics |
author2_original_writing_str_mv |
noLinkedField noLinkedField |
_version_ |
1796649071487746048 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03185nam-a2200409z--4500</leader><controlfield tag="001">993544277104498</controlfield><controlfield tag="005">20231214133540.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr|mn|---annan</controlfield><controlfield tag="008">202102s2018 xx |||||o ||| 0|eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)4920000000094235</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/43025</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)994920000000094235</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Marco Durante</subfield><subfield code="4">auth</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Charged Particles in Oncology</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="b">Frontiers Media SA</subfield><subfield code="c">2018</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 electronic resource (650 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Frontiers Research Topics</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">High-energy charged particles represent a cutting-edge technique in radiation oncology. Protons and carbon ions are used in several centers all over the world for the treatment of different solid tumors. Typical indications are ocular malignancies, tumors of the base of the skull, hepatocellular carcinomas and various sarcomas. The physical characteristics of the charged particles (Bragg peak) allow sparing of much more normal tissues than it is possible using conventional X-rays, and for this reason all pediatric tumors are considered eligible for protontherapy. Ions heavier than protons also display special radiobiological characteristics, which make them effective against radioresistant and hypoxic tumors. On the other hand, protons and ions with high charge (Z) and energy (HZE particles) represent a major risk for human space exploration. The main late effect of radiation exposure is cancer induction, and at the moment the dose limits for astronauts are based on cancer mortality risk. The Mars Science Laboratory (MSL) measured the dose on the route to Mars and on the planet’s surface, suggesting that a human exploration missions will exceed the radiation risk limits. Notwithstanding many studies on carcinogenesis induced by protons and heavy ions, the risk uncertainty remains very high. In this research topic we aim at gathering the experiences and opinions of scientists dealing with high-energy charged particles either for cancer treatment or for space radiation protection. Clinical results with protons and heavy ions, as well as research in medical physics and pre-clinical radiobiology are reported. In addition, ground-based and spaceflight studies on the effects of space radiation are included in this book. Particularly relevant for space studies are the clinical results on normal tissue complications and second cancers. The eBook nicely demonstrates that particle therapy in oncology and protection of astronauts from space radiation share many common topics, and can learn from each other.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">carbon ions</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">heavy ions</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Mars</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">proton therapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">radiotherapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">particle radiobiology</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">protons</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">space radiation protection</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Charged particles</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">space travel</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">2-88945-391-X</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Francis A. Cucinotta</subfield><subfield code="4">auth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Jay S. Loeffler</subfield><subfield code="4">auth</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-12-15 05:57:26 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2019-11-10 04:18:40 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5337595690004498&Force_direct=true</subfield><subfield code="Z">5337595690004498</subfield><subfield code="b">Available</subfield><subfield code="8">5337595690004498</subfield></datafield></record></collection> |